Abstract
Pancreatic malignancies continue to present a huge challenge not only to the surgeon, the gastroenterologist, and the oncologist, but to the radiologist as well. The poorly marginated, invasive nature of pancreatic ductal adenocarcinoma (PDA), the controversies regarding the clinical import of intraductal papillary mucinous neoplasms (IPMN), and the pitfalls introduced by tumor mimics are among the frustrating issues that make caring for affected patients so difficult. Dealing effectively with these tumors requires the highest possible level of imaging protocol optimization and radiologist expertise. Moreover, the patient with a pancreatic malignancy is best served when communication among imagers and clinicians flows freely, allowing for intelligent, effective patient care decisions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
